Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'

por Downey, C L, Simpkins, S A, Holliday, D L, Jones, J L, Jordan, L B, Kulka, J, Hanby, A M, Speirs, V
Publicado 2015

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer

por Downey, C L, Simpkins, S A, White, J, Holliday, D L, Jones, J L, Jordan, L B, Kulka, J, Pollock, S, Rajan, S S, Thygesen, H H, Hanby, A M, Speirs, V
Publicado 2014